Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
The PANBioRA consortium shared two new articles.
How to prevent bacterial infections that are often followed after an implantation of biomedical devices? HA hydrogels loaded with polyarginine (PAR) coul be a solution.
Due to the current Covid-19 global pandemic all around the world, the World Biomaterials Congress was postponed from end of May to mid December.